Breast Cancer ScreeningNCT00224224
A Comparison of Primary Care and Traditional Internal Medicine Residents
An observational study of Breast Cancer Screening and Cervical Cancer Screening, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
The goal of this study is to identify objective differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources. Read more about this study
- Who is it for?
- Ages 21 to 64 years
- Conditions the study is for
- Breast Cancer Screening, Cervical Cancer Screening, Cholesterol Screening
- How many people
- Not given
- Where
- 1 siteUnited States
- Study dates
- Jan 1995to Jan 2005
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 64 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients who are followed as outpatients by a Cornell affiliated internist at the Cornell Internal Medicine Associates (CIMA).
- Patients at New York Hospital who may or may not go on to be followed as outpatients at CIMA.
Who cannot join
- Patients who elect not to participate in the study.
Trial locations and contacts
1 site in 1 country.
United States1 site
New York Presbyterian Hospital-Weill Medical College
New York, New York, 10065
About this study
The goal of this study is to identify objective differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources. Specifically, this retrospective study will analyze the database collected by CLIMACS, the computer system at Cornell Internal Medicine Associates (CIMA). This system is used for clinical and administrative purposes; it manages and tracks patient's information and demographics, appointment booking, clinical diagnosis, prescriptions and medications, laboratory and radiology test, and consults. In our study, we will analyze a subset of the CLIMACS database from previous years.
Read the detailed description
Three areas will be examined:
- Clinical performance
- Continuity of care
- Utilization of resources
Clinical performance will be assessed using Health Plan Employer data and Information Set (HEDIS) performance standards. These standards were developed for the purposes of quality assessment, and in our study we will examine the following HEDIS standards:
- Breast Cancer Screening- the proportion of women between the ages of 52 and 64 who have had a mammogram within a two year period.
- Cervical Cancer Screening- the proportion of women between the ages of 21 and 64 who had a Pap test in the preceding 3 years.
- Cholesterol Screening- the proportion of patients ages 20 to 39 and 40-59 who have had their cholesterol tested at least once in the past five years.
- Asthma admission rate- the proportion of asthmatics admitted to the hospital for the care of asthma per year.
- Diabetic Standards-
- Admission for cellulitis/ 1000 diabetics per year.
- Admission for diabetes/ 1000 diabetics per year.
- Inpatient days per 100 diabetics per year.
- Prevalence of ischemic heart disease.
- Prevalence of severe renal disease.
- Diabetics with >2 hemoglobin A1C drawn per year.
Continuity of Care will be assessed by 3 different indicators:
- The proportion of visits that are made to the designated primary care provider of the number of visits made.
- The proportion of missed appointments of the total number of appointments.
- The proportion of walk in visits of the total number of appointments.
Resource utilization will be assessed by examining the following:
- Number of lab test per year per patient.
- Number of specialty consults per year per patient.
- Hospital admission rates per patient per year.
- Cost to medications. Confidentiality will be maintained throughout the study. In clinical practice access to CLIMACS is limited to the medical providers and administrators by individuals access codes. Furthermore, our study will remove specific identifiers to maintain the anonymity of both the patients and residents.
- Conditions
- Breast Cancer Screening, Cervical Cancer Screening, Cholesterol Screening, Asthma Admission Rate, Diabetes Management
- Keywords
- Clinical performance, Continuity of care, Utilization of resources
What is being measured
The primary outcome is the main question the study is designed to answer.
To identify the differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Sep 2005 (estimated)
- Study startJan 1995
- Study completionJan 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast Cancer ScreeningStudies of the same condition, open and under way.
- More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Retrospective
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Investigators
- Mary E Charlson, MD, Principal investigator, Weill Medical College of Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00224224
- Sponsor's protocol ID
- 9510000400 (Formerly 1095-071)
- Status last verified
- Mar 2008
- First submitted
- 20 Sep 2005
- Last updated
- 3 Apr 2008
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparison of Primary Care and Traditional Internal Medicine Residents
- ClinicalTrials.gov ID
- NCT00224224
- Acronym / sponsor ID
- 9510000400 (Formerly 1095-071)
- Conditions
- Breast Cancer Screening, Cervical Cancer Screening, Cholesterol Screening, Asthma Admission Rate, Diabetes Management
- Keywords
- Clinical performance, Continuity of care, Utilization of resources
- Study type
- Observational
- Recruitment status
- Completed
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Study start
- Jan 1995
- Study completion
- Jan 2005
- First posted
- 22 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to identify objective differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources. Specifically, this retrospective study will analyze the database collected by CLIMACS, the computer system at Cornell Internal Medicine Associates (CIMA). This system is used for clinical and administrative purposes; it manages and tracks patient's information and demographics, appointment booking, clinical diagnosis, prescriptions and medications, laboratory and radiology test, and consults. In our study, we will analyze a subset of the CLIMACS database from previous years.
Detailed description
Three areas will be examined:
- Clinical performance
- Continuity of care
- Utilization of resources
Clinical performance will be assessed using Health Plan Employer data and Information Set (HEDIS) performance standards. These standards were developed for the purposes of quality assessment, and in our study we will examine the following HEDIS standards:
- Breast Cancer Screening- the proportion of women between the ages of 52 and 64 who have had a mammogram within a two year period.
- Cervical Cancer Screening- the proportion of women between the ages of 21 and 64 who had a Pap test in the preceding 3 years.
- Cholesterol Screening- the proportion of patients ages 20 to 39 and 40-59 who have had their cholesterol tested at least once in the past five years.
- Asthma admission rate- the proportion of asthmatics admitted to the hospital for the care of asthma per year.
- Diabetic Standards-
- Admission for cellulitis/ 1000 diabetics per year.
- Admission for diabetes/ 1000 diabetics per year.
- Inpatient days per 100 diabetics per year.
- Prevalence of ischemic heart disease.
- Prevalence of severe renal disease.
- Diabetics with >2 hemoglobin A1C drawn per year.
Continuity of Care will be assessed by 3 different indicators:
- The proportion of visits that are made to the designated primary care provider of the number of visits made.
- The proportion of missed appointments of the total number of appointments.
- The proportion of walk in visits of the total number of appointments.
Resource utilization will be assessed by examining the following:
- Number of lab test per year per patient.
- Number of specialty consults per year per patient.
- Hospital admission rates per patient per year.
- Cost to medications. Confidentiality will be maintained throughout the study. In clinical practice access to CLIMACS is limited to the medical providers and administrators by individuals access codes. Furthermore, our study will remove specific identifiers to maintain the anonymity of both the patients and residents.
Study design
- Time perspective
- Retrospective
Who may qualify
- Ages
- 21 to 64 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Patients who are followed as outpatients by a Cornell affiliated internist at the Cornell Internal Medicine Associates (CIMA).
- Patients at New York Hospital who may or may not go on to be followed as outpatients at CIMA.
Key exclusion criteria (1 listed)
- Patients who elect not to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To identify the differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2008.
Related trials for Breast Cancer Screening
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
Enrolling by invitationObservational study
Harvesting Cells for Experimental Cancer Treatments
Melanoma, Gastrointestinal Cancer
RecruitingObservational study
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
RecruitingObservational study
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
Enrolling by invitationObservational study
Early Detection of Breast Cancer Among Syrian Women
Breast Cancer Detection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mary E Charlson, MD principal investigator
Weill Medical College of Cornell University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Breast Cancer Screening and Cervical Cancer Screening, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Apr 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To identify the differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources.. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2008.